Why We Supported This Campaign

Every day, we work to transform T-cell therapy, which we believe may become one of the pillars of cancer immunotherapy. We focus on the needs of our patients, knowing that what we do can contribute to supporting them in achieving their goals.

Recently, we invited a patient and their physician, who participated in one of our clinical trials, to come and talk to us about living with and treating cancer. We did this to help us understand the needs of our patients so that we can improve their experience with our therapies. Being part of Cancer Immunotherapy Month is another way for us to reinforce the message that everything we do is with the aim to deliver for cancer patients.

As one of the leaders in T-cell therapy, with clinical trials ongoing for multiple proprietary SPEAR T-cells in solid cancer tumor indications, we believe that fostering a broad understanding of TCR technology and the role of T-cells in the immune system is important. We see the Cancer Research Institute's reach and ability to educate and distill these concepts to the medical and the patient community, as key to improve understanding and acceptance of T-cell therapies.